Atlantic Coastal Acquisition Corp. II (ACAB) Stock Price, News & Analysis

Company Overview

Atlantic Coastal Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in financial services industry and mobility sector. The company was incorporated in 2021 and is based in New York, New York. Atlantic Coastal Acquisition Corp. II is a subsidiary of Atlantic Coastal Acquisition Management II LLC.

Key Stats

• Today's Range: $5.75 to $11.19
• 50-Day Range: $5.77 to $11.69
• 52-Week Range: $5.75 to $13.00
• Volume: 162,494 shs
• Average Volume: 28,012 shs
• Market Capitalization: $47.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ACAB Stock Analysis - Frequently Asked Questions

How have ACAB shares performed this year?

Atlantic Coastal Acquisition Corp. II's stock was trading at $10.58 at the beginning of the year. Since then, ACAB stock has decreased by 45.5% and is now trading at $5.77.
View the best growth stocks for 2024 here.

How do I buy shares of Atlantic Coastal Acquisition Corp. II?

Shares of ACAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Atlantic Coastal Acquisition Corp. II own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Atlantic Coastal Acquisition Corp. II investors own include Andretti Acquisition Corp. II (POLEU), Arogo Capital Acquisition (AOGO), Agriculture & Natural Solutions Acquisition (ANSC), Alpha Star Acquisition (ALSA), Alchemy Investments Acquisition Corp 1 (ALCY), AI Transportation Acquisition (AITR) and Aimfinity Investment Corp. I (AIMAU).

Company Calendar

• Today: 11/14/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Unclassified
• Industry: Holding & other investment offices
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:ACAB
• CUSIP: N/A
• CIK: 1893219
• Web: www.atlanticcoastalacquisition.com
• Phone: 248-890-7200
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 8,170,000
• Free Float: 720,000
• Market Cap: $47.14 million
• Optionable: Not Optionable
• Beta: 0.01